Research Interests

• Yang Yu (Yu) received his PhD degree from University of Macau (Macau) in Biomedical Sciences. He undertook his postdoctoral training at the University of Florida (USA), working between Weihong Tan’s group in the Chemistry Department for Bionanotechnology and Tumor Immunotherapy Research. In 2021, Yu started his independent research at Institute of Molecular Medicine (IMM), School of Medicine, Shanghai Jiao Tong University, as Principal Investigator (PI), Professor, and Doctoral Supervisor.

• Yu’s current research is focused on Biomaterials, DNA molecular engineering, Precision Immunotherapy and other related interdisciplinary fields. He also has developed a series of novel cancer therapeutic strategies for optical therapy, radiotherapy, targeted therapy and precision immunotherapy. Up to now, he has published over 50 international high-level SCI articles with an H-index of 30 and has received numerous awards and honours, including Outstanding Young Scholars from National Natural Science Foundation of China, Macao Science and Technology Award for Postgraduate Research, and the first prize of Baxter China Young Investigator Award.

Representative Articles

1. Yu Yang, Bo, Liu Yuan Liu, Jingqi Chen, Yujia Sun, Xiaoshu Pan, Jun Xu, Shujuan Xu, Zhuang Liu*, and Weihong Tan*. DNA-Based MXFs to Enhance Radiotherapy and Stimulate Robust Antitumor Immune Responses[J]. Nano Letters, 2022, 22(7): 2826-2834.

2. Xiaohao Liu, Dongsheng Mao, Yuchen Song, Liucun Zhu, Albertina N Isak, Cuicui Lu, Guoli Deng, Feng Chen, Fenyong Sun*, Yu Yang*, Xiaoli Zhu*, Weihong Tan*. Computer-aided design of reversible hybridization chain reaction (CAD-HCR) enables multiplexed single-cell spatial proteomics imaging, Science Advances2022,